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This newsletter was jointly developed and 
subject to editorial review by Jefferson 
School of Population Health and Lilly 
USA, LLC, and is supported through 
funding by Lilly USA, LLC.  The content 
and viewpoints expressed are those of the 
individual authors, and are not necessarily 
those of Lilly USA, LLC or the Jefferson 
School of Population Health.
It has been 5 years since we, in 
partnership with Eli Lilly and Company, 
introduced Prescriptions for Excellence in 
Health Care (PEHC), a unique newsletter 
series devoted to the evolving national 
quality improvement agenda.  Since its 
launch in 2007, the newsletter has been 
provided as a supplement to our Health 
Policy Newsletter (HPN).  This issue 
marks 2 important beginnings – a new 
4-part series on the present and future 
impact of health care reform and, as HPN 
goes exclusively electronic, the debut of 
PEHC as a stand-alone publication.  
Like many of our readers, I have 
followed the implementation of the 
Patient Protection and Affordable 
Care Act (ACA) with keen interest, 
some trepidation, and a certain amount 
of optimism.  As we go to press, it is 
almost 2 years since the passage of this 
historic, game-changing legislation that 
promises to influence how health care is 
delivered and reimbursed in the United 
States for decades to come.  
Debates continue to rage about the 
ACA’s design, its intended effects, 
and whose way is best.  But, lawsuits 
and court challenges by some states 
notwithstanding, the ACA and the 
overwhelming majority of its provisions 
are here to stay.    
Although the popular media tends 
to focus on the few hot-button issues 
(eg, charges of amendment violations, 
“death panels”), an astounding array of 
provisions have already gone into effect 
across the entire industry.  In the first 
year alone (2010), insurers faced a variety 
of new requirements, such as: increased 
mandatory reporting of administrative 
data, continued coverage of adult 
children under their parents’ policies 
(until the 26th birthday), strict limits on 
reasons for discontinuing coverage, and 
free preventive screening services for 
adults.  Nonprofit insurers were required 
to maintain a medical loss ratio of 85% 
or higher in order to take advantage of 
Internal Revenue Service tax benefits.  
Editorial
Health Reform: A Work In Progress 
By David B. Nash, MD, MBA
Editor-in-Chief
Prescriptions for Excellence in
HEALTH CARE
Prescriptions for Excellence in Health 
Care is brought to Health Policy 
Newsletter readers by Jefferson School 
of Population Health in partnership 
with Lilly USA, LLC to provide 
essential information from the quality 
improvement and patient safety arenas.
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Other provisions that went into 
effect in 2010 include new tax credits 
available to small businesses (those 
with 25 or fewer employees) to help 
with employee premium costs and the 
expansion of Medicare to small, rural 
hospitals and facilities. 
In January 2011, Medicare 
beneficiaries began to receive free 
preventive care as well as a 50% 
discount on the cost of covered 
brand-name prescription drugs for the 
Medicare Part D coverage gap (donut 
hole).  Grants became available to 
states to develop programs aimed 
at delaying the onset and reducing 
the prevalence of chronic conditions 
among Medicaid beneficiaries.  
Hospitals, too, have begun to feel 
the impact of ACA as the federal 
government ceased making payments 
to states for Medicaid services 
related to certain hospital-acquired 
infections – a precursor to a reduction 
in Medicare payments for preventable 
hospital admissions scheduled to take 
effect in 2012.  
On the policy front, the Centers for 
Medicare and Medicaid Services 
has met its deadline for developing 
the CMS Center for Medicare and 
Medicaid Innovation, the body that 
will oversee testing of innovative 
payment and delivery models.
In the summer of 2011, we convened 
a symposium to get a snapshot of how 
various provisions of the ACA have 
begun to affect health care quality and 
population health.  With presentations 
from a cross section of stakeholder 
groups, we had an opportunity to learn 
how things are going on the front 
lines, from primary care to long-term 
care to policy making.  Three of these 
presentations form the basis of the 
articles in this issue.
The first article, “The Role of Primary 
Care in Health Care Reform,” examines 
3 current ACA-related initiatives 
that have the potential to reinforce 
primary care as the foundation for 
assuring the success of health care 
reform.   
Prevention plays either a starring 
or supporting role in many ACA 
provisions.  The second article, “A 
New Model for Integrating Clinical 
Preventive Medicine into Patient 
Care,” describes one residency 
program’s approach to improving how 
preventive medicine specialists are 
prepared to meet the expectations of 
health reform.    
The third article is one that certainly 
piqued my interest.  Exploring another 
key component of health reform, 
“Leveraging Electronic Health Records 
in Comparative Effectiveness Research” 
translates a complex sounding concept 
into terms that are easily understood 
and thought provoking.
I hope that this issue and others in 
this series will shed new light on some 
of the changes that are occurring 
as health care reform unfolds.  As 
always, I welcome questions and 
comments from readers.  I can be 
reached at: david.nash@jefferson.edu.
David B. Nash, MD, MBA, is the Dean 
and the Dr. Raymond C. and Doris N. 
Grandon Professor of Health Policy at 
the Jefferson School of Population Health 
(JSPH) of Thomas Jefferson University 
in Philadelphia, PA. 
Health care reform in the United 
States was inevitable.  In the absence 
of any changes to federal law, 25% 
of total US Gross Domestic Product 
would have been spent on health care 
by 2025.  A system that provided 
financial incentives for services 
without regard for patient outcomes 
was bound to hit the wall.  We were 
spending nearly twice what the rest 
of the developed world spent on 
health care, yet measures of quality 
suggested that US health care was 
not twice as good.  It was time for a 
fundamental reevaluation. 
There was much speculation about 
why the biopharmaceutical industry 
jumped headlong into the health 
care reform debate in 2009.  The 
industry supported what became 
the Affordable Care Act (ACA) 
despite the enormous additional 
expenditures it imposed on 
biopharmaceutical companies. Why?  
The simplest answer is that the 
system’s flaws were catching up 
A Message from Lilly
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with it and producing results that 
were not in Americans’ best interests 
– most importantly, the patients who 
were its intended beneficiaries.
This issue of Prescriptions for 
Excellence in Health Care comes 
at a very uncertain time.  The US 
Supreme Court will decide the fate 
of at least the individual mandate in 
the ACA, if not the fate of the entire 
law.  Regardless of how the high 
court rules, the 2012 elections could 
result in a Republican president 
and a Republican-controlled 
Congress – 2 entities that have 
pledged to repeal the ACA.  If 
President Obama is reelected, he 
may face a Republican Congress 
that imposes limits on funding the 
implementation of certain ACA 
provisions.  And then there are the 
States, which have responsibility for 
insurance exchanges, the expansion 
of Medicaid, and other critical 
components of the new law.
The foregoing challenges aside, it 
is a very good time to discuss the 
issues presented on the following 
pages.  If the ACA survives, it 
must evolve.  Even its staunchest 
supporters admit that.  If it is 
repealed, it must be replaced with 
something else.  Otherwise, we’re 
in the same place we were 2 years 
ago – with millions of uninsured 
people, unsustainable growth in 
expenditures, and little to show in 
the way of improved outcomes and 
higher quality. 
In the biopharmaceutical industry, 
there are many opinions as to what 
such an improved system might 
look like, and I have my own.  The 
movement toward compensating 
those in the health care system 
for improved individual health 
outcomes is inexorable, but it will 
be a terribly complicated thing to 
do.  The ACA puts a number of 
“toes in the water” on the subject 
of paying for results, Accountable 
Care Organizations being the 
most prominent.  When so many 
different individuals and institutions 
are involved in the care of a single 
person, how do we distinguish who 
performed well from who performed 
poorly and, importantly, how do 
we compensate them accordingly?  
What about the role of the health 
care consumer in his or her own 
health?  What about prevention?
I believe that the age of health 
care “silos” will come to an end.  A 
system that pays only for products 
and services facilitates siloed 
providers, and vice versa.  The 
biopharmaceutical industry provides 
essential innovation for the benefit 
of patients and value for the health 
care system but is compensated 
solely on the number of pills and 
vials it sells.  I hope the business 
model for biopharmaceutical 
companies evolves to the point 
where they are seen as an integral 
part of producing better individual 
patient outcomes.  At Lilly, our 
corporate vision is “Improved 
Outcomes for Individual Patients.”  
These are not empty words.  They 
drive the actions of our employees 
across the world every day.
US health care reform is closer to 
the beginning than the end.  At 
least our county is now purposefully 
focused on real issues and real 
solutions.  It is imperative that this 
focus lead to a sustainable health 
care system that produces better 
outcomes for all Americans.
Barton R. Peterson, BS, JD, is Sr. 
Vice President, Corporate Affairs/
Communications at Eli Lilly and 
Company.
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Few discussions on health care reform 
fail to mention the importance of 
primary care and, indeed, primary care 
plays such a critical role in health care 
delivery that any successful health care 
reform effort will necessarily depend 
on a strong primary care foundation.  
At the present time, that foundation is 
not solid enough to fulfill its role.  It 
will need significant reinforcement if 
reform is to succeed.1
For a patient experiencing a new 
problem, primary care is generally 
the first contact with the health care 
system.  Comprehensive in nature and 
centered on the whole person rather 
than a specific disease process or organ 
system, primary care coordinates care 
given by different providers in different 
settings. It is continuous over time 
and, as such, is forward looking and 
prevention based.  
Although health care reform 
is multifaceted, with different 
orientations depending on the context, 
a majority of its goals target lowered 
costs, improved quality and safety, 
better access to care, and more patient-
centeredness.  By its very nature, 
primary care supports these goals; 
for example, studies of geographical 
variation in costs in this country have 
shown that areas with more primary 
care have lower costs.  On a macro 
scale, this is supported by data showing 
that countries with a higher percentage 
of primary care doctors also have lower 
costs. Outpatient quality improvement 
efforts have focused on primary care 
initiatives with specialist programs 
lagging behind.  Moreover, newer care 
delivery models such as the Patient-
Centered Medical Home (PCMH) are 
designed in part to improve both access 
and patient-centeredness.
Despite the concordance between the 
nature of primary care and the goals of 
reform, primary care is ill equipped to 
fulfill its potential foundational role.  
Consider the following:
•	At a mere 5% of total health 
expenditures, primary care is 
woefully underfunded.  It is 
trapped in a fee-for-service 
payment methodology that 
reimburses visits and does not 
support the goals of reform. 
•	Primary care is fragmented, with 
evidence revealing that in 1 year 
the average Medicare patient 
sees 2 primary care doctors and 5 
specialists working in 4 different 
locations.2
•	Primary care is increasingly 
isolated as fewer and fewer primary 
care physicians practice in the 
hospital setting. 
•	Primary care is time challenged, 
with one study documenting 
that it would take 7.4 hours per 
day to provide all recommended 
preventive care and another 
revealing that it would take 
10.6 hours per day to provide all 
recommended chronic care.3 
Despite recent efforts, including those 
contained in the Affordable Care 
Act, primary care doctors remain in 
short supply.  Market forces likely will 
exacerbate this problem.
Three initiatives currently under way 
or close to starting have the potential 
to help improve the situation for 
primary care. The first of these is 
the PCMH, a care delivery model 
innovation that seeks to improve the 
core primary care functions of access, 
comprehensiveness, coordination, and 
quality improvement. Although it does 
deliver results in these areas, the data 
are not as robust with regard to cost 
reduction. The extent to which PCMH 
is truly able to drive change depends 
primarily on payers supporting the 
concept.  In the absence of strong data 
on cost reduction, such payer support 
remains in question.
The second initiative currently 
affecting primary care is payment for 
meaningful use (MU) of electronic 
medical records (EMR). Legislated 
through the American Recovery 
and Reinvestment Act in 2009, final 
criteria for the first stage of MU were 
recently established, and the first wave 
of practices is now in the certifying 
process. Anecdotal evidence suggests 
that the criteria will represent a 
difficult stretch for many physician 
practices and therefore may not be 
a significant driver of change. On 
the positive side, the 2011 standards 
for National Committee for Quality 
Assurance PCMH certification include 
many of the same elements that are 
necessary for MU certification, so a 
practice that certifies as a meaningful 
user of EMR will be well on its way to 
PCMH certification as well.
The last initiative, one that begins 
soon, is the Medicare Shared Savings 
Program. Preliminary rules were 
The Role of Primary Care in Health Care Reform
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published in March of 2011, and 
the final rules are still pending at 
the time of this writing. While the 
term Accountable Care Organization 
(ACO) is used in other contexts, 
here it refers to a business structure 
of providers of traditional Medicare 
services who will contract with the 
Centers for Medicare and Medicaid 
Services to engage in a shared savings 
program. The sharing of savings is 
first predicated on the organization’s 
achievement of acceptable performance 
levels on specific quality measures. 
The preliminary rules describe 65 
such measures, many of which are 
outpatient, primary care-based 
measures. Five of the measures are MU 
measures, and there is a requirement 
that 50% of the ACO’s primary care 
doctors be certified as meaningful users 
of EMR by the ACO’s second year.  
Because ACOs will be held liable 
for losses incurred under the Shared 
Savings Program, they also must be 
risk-bearing entities with sufficient 
capital – a resource not typically 
associated with primary care 
physicians.  Given that participation in 
the ACO is entirely at the discretion of 
the primary care doctor, this initiative 
does have the potential to better fund 
primary care if the practitioners are 
able to leverage this with a strategically 
aligned capital partner.4
Although these 3 initiatives have 
different origins and different goals, 
they tie together and support each 
other. As noted, practices that can 
certify as meaningful users of EMR 
are well on the way to PCMH 
certification, and MU certification is 
critical for ACO participation. PCMH 
certification, in turn, goes a long way 
toward meeting the proposed ACO 
quality measures. Only the ACO is 
a true payment methodology reform 
but, to the extent that the PCMH is 
embedded in the ACO and driving 
its quality, the ACO may provide the 
PCMH with financial support. Many 
themes of reform – from cost reduction 
to quality improvement to better 
patient-centeredness – run through all 
3 of these initiatives.
Although each of these initiatives has 
the potential to improve the plight of 
primary care, a true bolstering of the 
foundational role of primary care (and 
thereby a true support of the delivery 
system as a whole) will depend on new 
payment mechanisms that support the 
goals of reform. To accomplish this 
will require fundamental reform that 
uncouples reimbursement from the 
individual visit and creates incentives 
for team building.5 
A reimbursement system that pays for 
visits will continue to produce visits 
without necessarily improving access, 
comprehensiveness, safety, or quality 
of care.  Conversely, a reimbursement 
system that rewards the goals of 
reform has the potential to address the 
challenges of primary care and, hence, 
improve the delivery system as a whole.
Kenneth Goldblum, MD, is Chief 
Medical Officer of Renaissance Medical 
Management Company.  He can be 
reached at kgoldblum@rmmcdocs.com. 
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The General Preventive Medicine 
Residency (GPMR) Program of the 
Johns Hopkins Bloomberg School 
of Public Health is one of the oldest 
and largest preventive medicine (PM) 
residency programs in the country.  
The mission of the residency program 
is as follows1:
To prepare physicians in the theoretical, 
practical, and clinical knowledge and 
skills essential to leadership roles in the 
design, management, and evaluation of 
population-based approaches to health.
Basic to this mission are 5 key goals:
•	To instill in residents the ability to 
synthesize clinical and population-
based approaches to disease 
prevention and health promotion
•	To view health issues on a broad 
continuum that ranges from local 
to international in perspective
•	To discover and apply knowledge 
toward the protection of the 
public’s health
•	To provide residents with the 
management and epidemiologic skills 
needed to address the overall health 
needs of underserved populations
•	To provide residents with 
the clinical skills needed to 
treat specific diseases that 
disproportionately affect 
underserved populations.1
Each year, approximately 10 resident 
physicians enter the GPMR Program 
after completing at least 1 year of 
clinical training in an Accreditation 
Council for Graduate Medical 
Education (ACGME)-accredited 
program.  One student is accepted 
directly from medical school through 
the match process and completes the 
required clinical training at Basset 
Healthcare Hospital in Cooperstown, 
NY.  Approximately half of the other 
9 residents who enter the program 
each year have completed a partial 
clinical residency in another specialty 
(eg, internal medicine, radiology, 
neurosurgery) and have been in 
practice for some time prior to entering 
the program.  The remaining residents 
have completed full clinical residencies 
(eg, pediatrics, family medicine, 
internal medicine).     
Like most PM residencies, the GPMR 
Program is 2 years of specialty-specific 
training that includes graduate level 
course work and hands-on rotation 
experiences.  Although some PM 
residencies spread the graduate 
course work and rotation experiences 
throughout the 2-year period, the 
GPMR Program has separated the 2 
disciplines into an academic (graduate 
course work) year and a practicum 
(rotation experience) year.    
During the academic year, residents 
have been full-time graduate students 
in the Master of Public Health 
(MPH) program at the Johns Hopkins 
Bloomberg School of Public Health.  
The school offers hundreds of 
classes in a wide variety of areas, and 
residents are encouraged to design a 
personalized curriculum that meets 
their interests and career goals.  The 
MPH course work has constituted 
about 60% to 70% of their time.  The 
remaining time has been dedicated 
to typical residency activities such 
as journal clubs, grand rounds, and 
numerous educational seminars/classes 
on various topics (eg, problem-solving 
skills in public health, health advocacy, 
public health preparedness, quality 
assessment/quality improvement, 
budgeting and financial management, 
conflict management and negotiation, 
strategic leadership principles).  
Residents have spent all 12 months 
of the practicum year doing elective 
rotations at a variety of sites to fulfill the 
core competencies of the residency (ie, 
biostatistics/epidemiology, health care 
management and administration, clinical 
preventive medicine, occupational/
environmental health).   The rotation 
sites have ranged from industry to 
academia to government (local, state, 
federal, and international) and include 
hospitals, managed care organizations, 
health departments, nongovernmental 
organizations, community-based 
organizations, pharmaceutical 
companies, and consulting firms.   
The following are examples of recent 
resident rotation sites: 
World Health Organization 
Pan American Health Organization 
Centers for Medicare and  
Medicaid Services 
Food and Drug Administration 
Office of the National Coordinator on 
Health Information Technology 
A New Model for Integrating Clinical Preventive Medicine into Patient Care
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Office of the Surgeon General
Agency for Healthcare Research  
and Quality 
Maryland State Health Department
Maryland General Assembly
Baltimore City Health Department
Capitol Hill
GlaxoSmithKline
Booz Allen
Discovery Channel
The Dr. Oz Show
Until recently, the GPMR Program 
had no formal requirements for direct 
patient care in the hospital or in 
any outpatient setting.  This policy 
changed as of July 1, 2011, when 
new ACGME requirements for PM 
went into effect.   PM residents now 
are required to have a minimum of 2 
months of direct patient care during 
each year of their residency (Figure 1).2 
We sought to implement this patient 
care experience in an innovative way, 
keeping in mind 3 critical goals: 
(1) Provide value to the GPMR 
residents, the Johns Hopkins 
health care system, and our 
patients 
(2) Focus on prevention/chronic 
care rather than acute care (eg, 
counseling individuals on health 
promoting behaviors such as diet, 
exercise, and tobacco use)
(3) Leverage our training in  
both clinical medicine and 
population health.   
To meet these requirements while 
accomplishing our goals, we created a 
new curriculum (clinical program) that 
will expose residents to the different 
ways preventive care can be delivered 
and integrated throughout an entire 
health care system.  
Beginning in September 2011, GPMR 
residents will spend one half day per 
week for 2 years in a Johns Hopkins 
Community Physicians ( JHCP) clinic, 
the primary care outpatient clinics at 
Johns Hopkins. Residents also will 
work with Johns Hopkins HealthCare, 
the health plan of Johns Hopkins that 
administers health care services across 
several different product lines.  Through 
didactic sessions, online modules, and 
working directly with physicians, health 
coaches/educators, and care managers, 
residents will learn how to assess disease 
risk, practice evidence-based behavioral 
counseling and risk factor reduction, 
apply shared decision-making strategies 
to generate self-management tools for 
patients, set up collaborative referrals 
to health care professionals, and utilize 
team-based management skills for 
lifestyle-related conditions.  
Residents also will learn about broader 
concepts of health care delivery and 
population management such as Patient-
Centered Medical Homes (PCMHs), 
Accountable Care Organizations, 
meaningful use of electronic health 
records, disease registries, and 
performance measurement/outcomes 
evaluation (eg, utilizing health risk 
assessments and administrative, pharmacy, 
and laboratory claims data).  Residents 
will spend a portion of their time seeing 
patients and providing preventive care, 
and a portion of their time working 
on projects to improve safety, quality, 
population management, and/or 
operations in a JHCP clinic, multiple 
clinics, or across the entire Hopkins 
health care system.  Some residents 
will work in a National Committee for 
Quality Assurance-recognized PCMH.    
Figure 1.  ACGME Program Requirements for Graduate Medical Education in  
Preventive Medicine
Source:  Preventive Medicine Residency Review Committee. Preventive Medicine Program Requirements. http://www.acgme.org/
acWebsite/downloads/RRC_progReq/380_preventive_medicine_PRs_07012011.pdf .  Accessed September 18, 2011. 
(continued on page 8)
ACGME Program Requirements for Graduate Medical Education in  
Preventive Medicine
Effective July 1, 2011
IV.A.6. Curriculum Organization and Resident Experiences
  IV.A.6.a.(2) Residents must have educational experiences within a patient 
care environment that address direct clinical issues relevant to their area of 
concentration.
   IV.A.6.a.(2).(a) Each resident must have progressive responsibility 
for direct patient care.
   IV.A.6.a.(2).(b) Each resident must have progressive responsibility for 
the management of health and provision of health care for a defined 
population, as specified for their area of preventive medicine.
  IV.A.6.d.(2) Residents must have a minimum of two months of direct patient 
care experience during each year of the program.
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Comparative Effectiveness Research 
(CER) has been identified as a key 
component of US health care reform. 
The Institute of Medicine defines CER 
as “the generation and synthesis of 
evidence that compares the benefits and 
harms of alternative methods to prevent, 
diagnose, treat, and monitor a clinical 
condition or to improve delivery of care” 
for the purpose of allowing “consumers, 
clinicians, purchasers, and policy 
makers to make informed decisions that 
will improve health care at both the 
individual and population levels.”1 
CER ultimately seeks to provide 
pragmatic knowledge that can be 
applied toward delivering “the right 
treatment to the right patient at the 
right time.”2 Achieving this goal in a 
complex health care environment will 
require robust, accessible data sources 
capable of providing detailed patient-
level information in a time- and cost-
efficient fashion. Electronic health 
records (EHRs) are well suited to fill 
that need, but current technical aspects 
and methodologies of using these 
systems as research tools are at an early 
stage of development.
The Federal Coordinating Council for 
CER (established by the American 
Recovery and Reinvestment Act of 
2009, which also included a $1.1 
billion appropriation for CER) 
advocated a strategic framework2 that 
reflects the importance of EHRs in the 
CER enterprise. As shown in Table 1, 
the core components of CER outlined 
by the Council are strongly influenced 
and enhanced by EHRs, particularly 
those with functionalities that allow 
interoperability and data exchange.  
 
EHRs also help address the 
disconnection between the vast amount 
of health care data that are available 
and our ability to access and organize 
those data in a way that is meaningful 
Leveraging Electronic Health Records in Comparative Effectiveness Research
By Andrew Masica, MD, MSCI and Ashley Collinsworth, MPH
Indeed, the landscape of medicine is 
changing and, at Johns Hopkins, we 
want to be ahead of the curve.  We 
used the new ACGME requirements 
as an opportunity to create a new 
model that better integrates preventive 
medicine into patient care.  We wanted 
this new model to provide value for the 
residents, value for the Johns Hopkins 
health care system, and above all, value 
for the many patients through our 
planned interactions.  We believe this 
new model does that because of its 
focus on promoting healthy behaviors 
through preventive care at multiple 
levels of the health care system.  
We look forward to sharing our 
experiences in the future and welcome 
questions and feedback from readers.  
Kevin L. Bowman, MD, MBA, MPH, is 
Chief Resident in the General Preventive 
Medicine Residency Program at Johns 
Hopkins Bloomberg School of Public Health. 
He can be reached at kbowman@jhsph.edu.  
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Table 1.  Relationships between the Comparative Effectiveness Research (CER) Strategic 
Framework and Electronic Health Records (EHRs)
CER Activity/Investment EHR Support of Activity/Investment  
Research Content •  End product of investigators applying EHRs effectively
 •  Accelerated research production time frame
Human and Scientific Capital  •  Human resources to extract and configure electronic data
 •  EHR appropriate study design and analysis methodologies
 •  Hardware/software that facilitates research 
 
Data Infrastructure •  Longitudinal patient registries
 •  Development of distributive data networks
Dissemination and Translation •  Clinical decision support embedded into EHR workflows
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for CER. More than ever before, 
health care is “information rich,” as 
interactions between clinicians and 
patients produce a myriad of data 
points including diagnoses, laboratory 
results, images, interventions, and 
responses to treatments.3 
Historically, it has been difficult to 
use data collected as a part of routine 
patient care to perform research 
efficiently because the material of 
interest often was buried in paper 
charts or archived records and 
scattered across the siloed care sites. 
This incongruity has hampered the 
development of evidence to determine 
which intervention(s) works best for 
individual patients. EHRs offer a 
potential mechanism to identify and 
compile relevant clinical information 
for the full spectrum of patients across 
the continuum of care, to structure 
that data, and to enable appropriate 
comparisons of treatments from a 
single source. 
Until the recent movement toward 
widespread EHR implementation, the 
type of original research (excluding 
systematic literature reviews) that 
would satisfy criteria as a CER 
study would necessitate undertaking 
a clinical trial, conducting costly 
and time-consuming manual 
audits of paper charts, or relying on 
administrative data, which may be 
inaccurate and lacking in granular 
clinical information. 
Although randomized controlled trials 
(RCTs) have long been considered the 
gold standard for comparing efficacy, 
these types of studies are performed 
in highly controlled environments 
in which patients are selected based 
on strict inclusion criteria and in 
which treatment adherence is closely 
monitored. Research regulations, study 
logistics, and negative perceptions of 
research in certain populations often 
make it difficult or impossible to 
include certain subgroups (eg, children, 
pregnant women, the elderly, minorities, 
people with multiple chronic conditions, 
those with rare diseases) in clinical 
trials.4 Thus, the results of RCTs often 
have limited generalizability to an 
affected patient population, whereas a 
central tenet of CER is to determine 
what works in “real world” settings.5 
Lastly, RCTs are expensive and cannot 
be modified easily to include additional 
patient data over time or account for 
emerging care improvements. 
EHRs also have a clear advantage over 
purely administrative data sources in 
retrospective studies, as they contain 
access to discrete, longitudinal 
observations (eg, blood pressure 
measurements, serial laboratory 
tests) that can be used to strengthen 
statistical models pertaining to the 
outcomes of interest.6  
Early experience using EHRs as tools 
in CER has shown some promising 
results,7 but methodological and 
practical challenges must be addressed 
to leverage these systems to their full 
potential. Current EHRs are designed 
for frontline patient care delivery rather 
than for research.  As such, EHR data 
quality is subject to the idiosyncrasies 
of daily practice operations (eg, patients 
skipping appointments with resultant 
long intervals between observations, 
variations in provider behavior) and 
does not match the quality of data 
garnered from clinical trials. 
Likewise, treatment decisions in practice 
generally are determined by patient- 
and provider- specific factors rather 
than randomly, so observational studies 
relying on EHR data need analytic 
techniques that account for confounding. 
Another major obstacle in use of 
EHRs for CER is missing data. 
This issue stems largely from the 
relative immaturity of these systems 
and the recording of information in 
inaccessible “free text” fields, rendering 
it essentially lost to the researcher 
without manual chart review.  With 
the exception of a few early adopter 
health care delivery organizations, 
most EHR patient populations have 
accrued less than 5 years of data. This 
can reduce the available sample size 
when retrospectively evaluating the 
associations between interventions and 
outcomes in chronic diseases because 
new user designs (wherein only those 
patients with an incident disease 
diagnosis captured in the EHR are 
eligible for the cohort) are optimal for 
these types of studies to minimize bias.8 
Finally, the lack of standardization 
among vendors has hampered 
data-sharing efforts between sites.  
With disparate EHRs, a significant 
amount of data transformation and 
configuration are required for systems 
to exchange information.9            
Applied solutions to the aforementioned 
challenges are actively being pursued 
by the CER and medical informatics 
communities. With a wide variety 
of uses, natural language processing 
(NLP) appears to be an extremely 
potent tactic to access data trapped in 
EHR free text fields, and the Agency 
for Healthcare Research and Quality 
(AHRQ) currently is funding a grant 
to create a common NLP platform 
that can interface with EHR data to 
conduct CER.10 Statistical methods, 
such as propensity scoring and inverse 
probability weighting,11,12 have been 
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used successfully to help counter 
potential confounding in observational 
studies using EHR data. 
The “Meaningful Use of EHRs” 
incentive program and plans for 
electronic reporting of Centers for 
Medicare and Medicaid Services Core 
measures has heightened the emphasis 
on standardization of EHR data 
element specifications, and data-sharing 
consortiums between systems, intended 
to support CER, also are developing 
independently.13 Pooling data among 
multiple sites will resolve sample size 
problems and facilitate procuring CER 
information on subgroups. 
Given that several federal agencies 
are sponsoring CER (eg, AHRQ’s 
Effective Health Care Program, 
National Institutes of Health, and 
the recently formed Patient-Centered 
Outcomes Research Institute) as well 
as the interests of industry in this area, 
the pace of innovation surrounding use 
of EHRs in CER likely will be brisk. 
Even though EHRs are viewed as 
a part of larger systemic changes to 
drive health care improvements,3 
expectations surrounding EHRs in 
CER must be pragmatic. EHRs should 
be promoted as powerful tools that can 
facilitate CER efficiency rather than as 
a singular solution. The broad rollout 
of EHRs across US health care delivery 
organizations affords a window of 
opportunity to deploy these systems 
in a way that will help reach the vision 
of CER as a valuable resource for 
informed health care decision making.
Andrew Masica, MD, MSCI, is the 
Director of Clinical Effectiveness for the 
Baylor Health Care System in Dallas, 
TX.  He can be reached at andrew.
masica@baylorhealth.edu.  
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Key Health Reform Web Sites
Starting in 2010 and continuing through 2014, the Affordable Care Act will 
be implemented, increasing access to affordable health care for individuals, 
families, seniors, and businesses.  The following links to time lines illustrate 
implementation of the legislation. 
http://www.whitehouse.gov/healthreform/timeline
The implementation time line below from the Kaiser Family Foundation is an 
interactive tool designed to explain how and when the provisions of the health 
reform law will be implemented over the next several years.
http://healthreform.kff.org/timeline.aspx
Electronic Health Record Incentive Program
The Medicare and Medicaid Electronic Health Record (EHR) Incentive 
Programs will provide incentive payments to eligible professionals, eligible 
hospitals, and critical access hospitals as they adopt, implement, upgrade, or 
demonstrate meaningful use of certified EHR technology.
http://www.cms.gov/ehrincentiveprograms/
Medicare Shared Savings Program
The Medicare Shared Savings Program provides incentives for participating 
health care providers who agree to work together and become accountable for 
coordinating care for patients.  Providers who band together through this model 
and who meet certain quality standards based upon, among other measures, 
patient outcomes and care coordination among the provider team, may share in 
the savings they achieve for the Medicare program.  The higher the quality of 
care providers deliver, the more shared savings the providers may keep. 
https://www.cms.gov/sharedsavingsprogram/05_News.asp
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